First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and Advances of New Therapeutics

Medicine and Dentistry

• Neurofibromatosis 100%
• Neurofibromatosis Type I 50%
• Arteriovenous Malformation 50%
• Neoplasm 25%
• Noonan Syndrome 25%
• Disease Predisposition 25%
• Schwannomatosis 25%
• Capillary 25%
• Congenital Malformation 25%
• Tumor Progression 25%
• Neurofibromatosis Type II 25%
• Germline Mutation 25%
• Malformation Syndrome 25%
• Costello Syndrome 25%
• Noonan Syndrome with Multiple Lentigines 25%
• Cardiofaciocutaneous Syndrome 25%
• Legius Syndrome 25%
• Nervous System 25%
• Mitogen-Activated Protein Kinase 25%
• Pervasive Developmental Disorder 25%